What You Should Know:
– MBX Capital has secured over $100M in capital commitments to invest in early-stage biotech and health tech companies, specifically focusing on “deep health” solutions that address diseases linked to environmental…
Continue Reading
What You Should Know:
– Chai Discovery has secured a $130M Series B financing round, propelling its valuation to $1.3 billion just months after emerging from stealth.
– Co-led by Oak HC/FT and General Catalyst, the…
Continue Reading
Image Credit: freepik
What You Should Know:
– Scientists at the Icahn School of Medicine at Mount Sinai have developed a new artificial intelligence tool called V2P (Variant to Phenotype) that identifies not only disease-causing genetic…
Continue Reading
We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Tiffany Callahan, Lead Architect of Agentic AI Systems at SandboxAQ. As a…
Continue Reading
We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is James Hamrick, MD, MPH, Chairman of the Caris Precision Oncology Alliance at Caris…
Continue Reading
We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Jeff Gombala, Founder and CEO at Evidexa. Jeff Gombala started Helios Innovation…
Continue Reading
We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is David Lazerson, Co-Founder and CEO at Briya.Briya started in 2020 with a…
Continue Reading
What You Should Know:
– Valinor has launched with $13M in seed funding to tackle one of the pharmaceutical industry’s most expensive challenges: clinical trial failure led by CRV and Harpoon Ventures.
– The company uses…
Continue Reading
What You Should Know:
– Accenture has made a strategic investment in Ryght AI through its venture capital arm, aiming to modernize the sluggish clinical trial process. Ryght AI utilizes “agentic AI” and its proprietary…
Continue Reading
Doug Besch, Chief Product and Chief Technology Officer at OptimizeRx
Consumers are increasingly learning about potential drug therapies from advertising across the media channels they use regularly – whether it be broadcast or streaming TV,…
Continue Reading
